Positions

Overview

  • Dr. Allon is Professor of Medicine at University of Alabama at Birmingham, where he serves as the Associate Director for Clinical Affairs and the Medical Director of Dialysis Operations in the Division of Nephrology. He has a longstanding clinical research interest in dialysis, and in particular in vascular access for hemodialysis. He was the P.I. for several clinical dialysis trials sponsored by NIH, including HEMO, DAC, and HFM. He has published over 100 peer-reviewed manuscripts on various aspects of vascular access. Finally, he has been an invited speaker at numerous nephrology meetings on various topics related to vascular access.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 KDOQI Clinical Practice Guideline for Vascular Access: 2019 UpdateAmerican Journal of Kidney Diseases.  75:S1-S164. 2020
    2020 Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortalityASAIO Journal.  268-276. 2020
    2019 Second-Chance Placement of Hemodialysis Patients After Involuntary Discharge for Disruptive BehaviorAmerican Journal of Kidney Diseases.  74:544-548. 2019
    2019 Clinical Outcomes and Economic Impact of Starting Hemodialysis with a Catheter after Predialysis Arteriovenous Fistula CreationAmerican Journal of Nephrology.  50:221-227. 2019
    2019 Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting OrganismAmerican Journal of Nephrology.  50:126-132. 2019
    2019 Quantification of Complications of Tunneled Hemodialysis CathetersAmerican Journal of Kidney Diseases.  73:462-464. 2019
    2019 Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis PatientsAmerican Journal of Nephrology.  49:11-19. 2019
    2018 Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a CatheterAmerican Journal of Kidney Diseases.  72:509-518. 2018
    2018 Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation OutcomesAmerican Journal of Nephrology.  48:56-64. 2018
    2018 Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort StudyAmerican Journal of Kidney Diseases.  71:677-689. 2018
    2018 Lessons From International Differences in Vascular Access Practices and OutcomesAmerican Journal of Kidney Diseases.  71:452-454. 2018
    2016 Central Venous Occlusion in the Hemodialysis PatientAmerican Journal of Kidney Diseases.  68:803-807. 2016
    2016 Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney DiseaseAmerican Journal of Nephrology.  43:334-340. 2016
    2015 Influence of Kidney Function on Risk of Supratherapeutic International Normalized Ratio-Related Hemorrhage in Warfarin Users: A Prospective Cohort StudyAmerican Journal of Kidney Diseases.  65:701-709. 2015
    2015 Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysisAmerican Journal of Kidney Diseases.  66:84-90. 2015
    2013 Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patientsAmerican Journal of Kidney Diseases.  62:1122-1129. 2013
    2013 Predialysis vascular access surgery in patients with failing kidney transplantsAmerican Journal of Kidney Diseases.  62:398-400. 2013
    2013 Influence of kidney function on risk of hemorrhage among patients taking warfarin: A cohort studyAmerican Journal of Kidney Diseases.  61:354-357. 2013
    2012 Association of hemodialysis central venous catheter use with ipsilateral arteriovenous vascular access survivalAmerican Journal of Kidney Diseases.  60:983-989. 2012
    2012 Predicting successful arteriovenous fistula creationAmerican Journal of Kidney Diseases.  60:498. 2012
    2012 Association of factor V gene polymorphism with arteriovenous graft failureAmerican Journal of Kidney Diseases.  59:682-688. 2012
    2012 Peripherally inserted central catheters and other intravascular devices: How safe are they for hemodialysis patients?American Journal of Kidney Diseases.  60:510-513. 2012
    2011 Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturationAmerican Journal of Kidney Diseases.  58:437-443. 2011
    2011 Arteriovenous graft placement in predialysis patients: A potential catheter-sparing strategyAmerican Journal of Kidney Diseases.  58:243-247. 2011
    2011 Fistula first: Recent progress and ongoing challengesAmerican Journal of Kidney Diseases.  57:3-6. 2011
    2010 Warfarin dosing in patients with impaired kidney functionAmerican Journal of Kidney Diseases.  56:823-831. 2010
    2010 A physiologic-based approach to the treatment of acute hyperkalemiaAmerican Journal of Kidney Diseases.  56:578-584. 2010
    2010 Practical Vancomycin Dosing in Hemodialysis Patients in the Era of Emerging Vancomycin Resistance: A Single-Center ExperienceAmerican Journal of Kidney Diseases.  55:1163-1165. 2010
    2009 Treatment Guidelines for Dialysis Catheter-Related Bacteremia: An UpdateAmerican Journal of Kidney Diseases.  54:13-17. 2009
    2009 Treatment of Dialysis Catheter-Related Enterococcus Bacteremia With an Antibiotic Lock: A Quality Improvement ReportAmerican Journal of Kidney Diseases.  53:107-111. 2009
    2008 In ReplyAmerican Journal of Kidney Diseases.  52:198. 2008
    2008 Vascular Access: Core Curriculum 2008American Journal of Kidney Diseases.  51:702-708. 2008
    2008 Prophylaxis Against Dialysis Catheter-Related Bacteremia: A Glimmer of HopeAmerican Journal of Kidney Diseases.  51:165-168. 2008
    2007 In ReplyAmerican Journal of Kidney Diseases.  50:1052. 2007
    2007 Treatment of Dialysis Catheter-Related Staphylococcus aureus Bacteremia With an Antibiotic Lock: A Quality Improvement ReportAmerican Journal of Kidney Diseases.  50:289-295. 2007
    2007 Arteriovenous Grafts Still Have a Place in DialysisAmerican Journal of Kidney Diseases.  49:873-874. 2007
    2006 In ReplyAmerican Journal of Kidney Diseases.  48:181-182. 2006
    2006 Needle Infiltration of Arteriovenous Fistulae in Hemodialysis: Risk Factors and ConsequencesAmerican Journal of Kidney Diseases.  47:1020-1026. 2006
    2006 Effect of change in vascular access on patient mortality in hemodialysis patientsAmerican Journal of Kidney Diseases.  47:469-477. 2006
    2005 Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomesAmerican Journal of Kidney Diseases.  46:501-508. 2005
    2005 Shorter unassisted patency of vascular access after angioplasty in women [1] (multiple letters)American Journal of Kidney Diseases.  46:167. 2005
    2005 Saving infected catheters: Why and howBlood Purification.  23:23-28. 2005
    2004 Dialysis catheter-related bacteremia: Treatment and prophylaxisAmerican Journal of Kidney Diseases.  44:779-791. 2004
    2004 Vascular access stenosis: Comparison of arteriovenous grafts and fistulasAmerican Journal of Kidney Diseases.  44:859-865. 2004
    2004 Associations with predialysis vascular access managementAmerican Journal of Kidney Diseases.  43:1008-1013. 2004
    2003 Interventional nephrology: Work in progressAmerican Journal of Kidney Diseases.  42:388-391. 2003
    2001 Clinical consequences of infected arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases.  38:975-978. 2001
    2001 Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patientsAmerican Journal of Kidney Diseases.  37:945-953. 2001
    2000 Natural history of arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases.  36:68-74. 2000
    1998 Prospective evaluation of an anemia treatment algorithm in hemodialysis patientsAmerican Journal of Kidney Diseases.  32:635-641. 1998
    1996 Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterolAmerican Journal of Kidney Diseases.  28:508-514. 1996
    1995 Adaptation to phosphate depletion in opossum kidney cellsBiochemical and Biophysical Research Communications.  216:141-147. 1995
    1995 Effect of albuterol treatment on subsequent dialytic potassium removalAmerican Journal of Kidney Diseases.  26:607-613. 1995
    1993 Calcitriol stimulates Na(+)-Pi cotransport in a subclone of opossum kidney cells (OK-7A) by a genomic mechanism.American Journal of Physiology.  264:F404-F410. 1993
    1993 Calcitriol stimulates Na+-P(i) cotransport in a subclone of opossum kidney cells (OK-7A) by a genomic mechanismAmerican Journal of Physiology.  264. 1993
    1993 Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal diseaseAmerican Journal of Medicine.  94:475-482. 1993
    1992 Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.American Journal of Kidney Diseases.  19. 1992
    1992 CorrespondenceAmerican Journal of Kidney Diseases.  19:391. 1992
    1991 Cigarette use and hyponatremia in schizophrenic patients [11]American Journal of Psychiatry.  148:688-689. 1991
    1991 Effects of maleic acid on renal phosphorus transport: Role of dietary phosphorusAmerican Journal of Physiology.  261. 1991
    1990 Acute renal failure due to ciprofloxacinArchives of Internal Medicine.  150:2187-2189. 1990
    1990 Interaction of captopril and ibuprofen on glomerular and tubular function in humans.American Journal of Physiology.  259:F233-F238. 1990
    1990 Renal abnormalities in sickle cell diseaseArchives of Internal Medicine.  150:501-504. 1990
    1990 Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus (Reply)Archives of Internal Medicine.  150:2420. 1990
    1990 Interaction of captopril and ibuprofen on glomerular and tubular function in humansAmerican Journal of Physiology.  259. 1990
    1990 Role of cigarette use in hyponatremia in schizophrenic patientsAmerican Journal of Psychiatry.  147:1075-1077. 1990
    1989 Calcitriol in prolonged hypocalcemia due to the tumor lysis syndromeAnnals of Internal Medicine.  110:162-164. 1989
    1989 Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidusArchives of Internal Medicine.  149:1123-1126. 1989
    1989 Nebulized albuterol for acute hyperkalemia in patients on hemodialysisAnnals of Internal Medicine.  110:426-429. 1989
    1989 Protein S and C antigen levels in proteinuric patients: Dependence on type of glomerular pathologyAmerican Journal of Hematology.  31:96-101. 1989
    1989 Tubulointerstitial Nephritis Due to VancomycinAmerican Journal of Kidney Diseases.  14:512-515. 1989
    1988 Hyperphosphatemia, Hypocalcemia, and Renal Failure in a Patient With Acute LeukemiaAmerican Journal of Kidney Diseases.  11:442-445. 1988
    1988 Minimal change glomerulonephropathy and interstitial infiltration with mycosis fungoidesAmerican Journal of Medicine.  84:756-759. 1988
    1986 Prolonged Hypotension After Initial Minoxidil DoseArchives of Internal Medicine.  146:2075-2076. 1986

    Chapter

    Year Title Altmetric
    2017 Infectious Complications From Vascular Access.  64-71.e1. 2017
    2017 Vascular Access for Hemodialysis in Adults.  23-39.e2. 2017
    2014 Venous catheter access: The basics 2014
    2014 Venous catheter infections and other complications 2014
    2013 Disorders of potassium metabolism.  90-99. 2013

    Research Overview

  • Vascular access for dialysis
  • Education And Training

  • Doctor of Medicine, University of Michigan System : Ann Arbor 1982
  • Bachelor's Degree in Biomedical Sciences, University of Michigan System : Ann Arbor 1980
  • Emory University Hospital Systems, Internship 1983
  • Emory University Hospital Systems, Residency 1985
  • Emory University Hospital Systems, Postdoctoral Fellowship 1987
  • Full Name

  • Michael Allon